Scientific Program

  09:00 – 10:00

Exhibition & Networking Area (Manhattan 10-13)

REGISTRATION AND REFRESHMENT

  10:00 – 12:00

Plenary hall (Manhattan 1-9)

OPENING PLENARY SESSION: SETTING THE STAGE FOR CaReMeLO

Chair: Avraham Karasik, Tel Aviv University, Israel

10:00 – 10:10
WELCOME AND CONFERENCE GOALS
Avraham Karasik, Tel Aviv University, Israel
Agnieszka Mastalerz-Migas, Polish Society of Family Medicine (PTMR), Poland

KEYNOTE LECTURES: 

10:10 – 10:30
 IS TREATING OBESITY FIRST THE RIGHT APPROACH IN CaReMeLO PATIENTS?
Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland

10:30 – 10:50
CUTTING-EDGE STRATEGIES FOR PREVENTING AND MANAGING CARDIAC DISEASE IN CaReMeLO SYNDROME
Eberhard  Standl, Helmholtz Diabetes Centre, Germany

10:50 – 11:10
RENAL RENAISSANCE: TRANSFORMING KIDNEY CARE
Hiddo Heerspink,
University Medical Center Groningen, Netherlands

11:10 – 11:30
OVERCOMING PRIMARY CARE CHALLENGES IN MANAGING CaReMeLO PATIENTS
Shlomo Vinker, Tel Aviv University, Israel

11:30 – 11:50
PRE-DIABETES AND CARDIOVASCULAR RISK – WHAT IS NEW?
Brij Mohan Makkar, Diabetes & Obesity Centre, India

11:50 – 12:00
Panel discussion

(12:00 – 12:10) Short technical break

  12:10 – 13:10

Plenary hall (Manhattan 1-9)

INDUSTRY SYMPOSIUM

Industry session not included in the main event CME/CPD credit. For more information, please click here.

  13:10 – 14:10

Exhibition & Networking Area (Manhattan 10-13)

LUNCH, NETWORKING & ORAL PRESENTATIONS

Chair: Małgorzata Koziarska-Rościszewska, Medical University of Lodz, Poland

13:20-13:28
THE DEVELOPMENT AND IMPLEMENTATION OF AN INTEGRATED MULTI-MORBIDITY MODEL OF CARDIOVASCULAR-RENAL (KIDNEY)-METABOLIC CARE IN LONDON, UK
Ciara A. Doherty,
Guys and St Thomas NHS Foundation trust, United Kingdom

13:28-13:36
THE ROLE OF INTEGRATED MULTI-SPECIALIST PHARMACISTS IN THE DELIVERY OF A MULTI-MORBIDITY CARDIOVASCULAR-RENAL (KIDNEY)-METABOLIC MODEL OF CARE IN LONDON, UK
Jaskiran Sanghera,
Kings College Hospital NHS trust, United Kingdom

13:36-13:44
SOCIAL ATTITUDES, FAMILY SUPPORT, AND SELF-STIGMA IN ADULT POLISH WOMEN USING ANTI-OBESITY MEDICATIONS
Tomasz Witaszek, Indywidualna Praktyka Lekarska, Poland

13:44-13:52
STRATEGIES TO IMPROVE THERAPEUTIC COMPLIANCE OF CAREMELO PATIENTS
Justyna Tymińska, Lazarski University, Poland

13:52-14:00
USING THE CONSTRAINED-DISORDER-PRINCIPLE-BASED SECOND-GENERATION ARTIFICIAL INTELLIGENCE SYSTEM FOR IMPROVING THE RESPONSE TO THERAPIES FOR CARDIOMETABOLIC DISORDERS
Yaron Ilan, Hebrew University Hadassah Medical Center, Israel

14:00-14:08
PREVALENCE AND IMPACT OF COMORBIDITIES IN PRIMARY SJÖGREN’S SYNDROME: A RETROSPECTIVE STUDY
Ana Guida Araujo Freitas, USF Beira Saúde, Portugal

  14:10 – 15:40

Plenary hall (Manhattan 1-9)

SESSION 1: REAL-WORLD CASE STUDIES AND EXPERT INSIGHTS

Moderator: Baruch Itzhak, Clalit Health Services, Israel

Case Discussions:

14:10 – 14:30
Asymptomatic Patients with Diabetes
Josep Vilaseca, University of Vic – University of Central Catalonia, Spain

14:30 – 14:50
Patient with HFpEF
Jan Biegus, Wroclaw Medical University, Poland

14:50 – 15:10
Patient with Renal Involvement
Mateusz Szmidt, Medical University of Białystok, Poland

15:10 – 15:30
Patient with Obesity, Diabetes and Atrial Fibrillation
Alina Kuryłowicz, Center of Postgraduate Medical Education, Poland

15:30 -15:40
Panel discussion

  15:40 – 16:10

Exhibition & Networking Area (Manhattan 10-13)

COFFEE BREAK AND NETWORKING

 

15:55 – 16:05
Shape the Future of Care: Join UNLOKall: Multidisciplinary Academy
Catarina Morais, UNLOK, Portugal

  16:10 – 17:10

Plenary hall (Manhattan 1-9)

INDUSTRY SYMPOSIUM

Industry session not included in the main event CME/CPD credit. For more information, please click here.

(17:10 – 17:20) Short technical break

  17:20 – 18:50

Plenary hall (Manhattan 1-9)

TRANSFORMING CaReMeLO CARE: BREAKTHROUGHS FROM 2024 RCTs

Chair: Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland

17:20 – 17:50
EXPANDING THE BOUNDARIES OF THERAPEUTICS: GAME-CHANGING EVIDENCE
Lee Kaplan, Obesity and Metabolism Institute in Boston, USA

17:50 – 18:20
HEART DISEASE IN FOCUS: TRANSFORMING OUTCOMES IN THE CaReMeLO PATIENT
Avraham Karasik, Tel Aviv University, Israel

18:20 – 18:50
Panel Discussion: TURNING EVIDENCE INTO PRACTICE FOR THE CaReMeLO PATIENT
Moderator: Lee Kaplan, Obesity and Metabolism Institute in Boston, USA

Panelists:
Karolina Kłoda, Polish Society of Family Medicine (PTMR), Poland
Mariusz Wyleżoł, Polish Society for Obesity Treatment, Poland
Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland
Justyna Ledwoch, Polish Society of Family Medicine (PTMR), Poland

  18:50 – 20:00

Exhibition & Networking Area (Manhattan 10-13)

WELCOME RECEPTION, ORAL PRESENTATIONS & NETWORKING

Chairs: Magdalena Bujnowska-Fedak, Wroclaw Medical University, Poland
Małgorzata Koziarska-Rościszewska, Department of Family Medicine – Medical University of Lodz, Poland

19:00-19:08
AN APPLICATION OF URINARY PEPTIDOMICS AND IN SILICO METHODS TO GUIDE MULTIFACTORIAL INTERVENTION IN CHRONIC KIDNEY DISEASE
Agnieszka Latosinska, Mosaiques Diagnostics, Germany

19:08-19:16
TELOMERE LENGTH AS A BIOMARKER IN DIABETIC KIDNEY DISEASE
Yanina Rebrova, D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences, Ukraine

19:16-19:24
 TLT-1 AS A POTENTIAL INTERVENTIONAL TARGET IN CARDIOVASCULAR DISEASE
Valance Washington, Oakland University, USA

19:24-19:32
THE DUAL IMPACT OF CHOLESTEROL AND PULSE PRESSURE ON CHRONIC KIDNEY DISEASE OUTCOMES
Suela Mumajesi, Mother Teresa Hospital Tirana, Albania

19:32-19:40
THE ROLE OF SGLT2 INHIBITORS IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE – THE RESULTS OF ONE TERTIARY CENTER
Milena K. Nikolova, Clinic of Nephrology, University Hospital, Bulgaria

19:40-19:48
LOW-FREQUENCY ULTRASOUND AS A THERAPEUTIC ENHANCER OF RENIN-ANGIOTENSIN SYSTEM INHIBITOR EFFECTS IN ENDOTHELIAL, RENAL, AND HEPATIC CELLS: FOCUS ON CELLULAR FUNCTION AND INFLAMMATION MARKERS
Ieva Čiapienė, Institute of Cardiology, Lithuanian University of Health Sciences, Lithuania

19:48-19:56
GUT MICROBIOME DYSBIOSIS AND CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME: IS THERE A LINK?

Diana Przeworska, Janusz Korczak Specialist Hospital, Poland

  08:30 – 09:30

Plenary hall (Manhattan 1-9)

SESSION 2: LEADING THE CHANGE – FAMILY PHYSICIANS IN CaReMeLO

Chairman: Thomas Frese, Institute of General Practice and Family Medicine, Germany

Best Practices and Innovations:

08:30 – 08:45
ISRAELI EXPERIENCE IN PCP LEADERSHIP
Avraham Karasik, Tel Aviv University, Israel

08:45 – 09:00
PCP ROLE IN CaReMeLO TREATMENT IN POLAND AND CENTRAL EUROPE
Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland

09:00 – 09:15
THE SPANISH EXPERIENCE
Josep Vilaseca, University of Vic – University of Central Catalonia, Spain

09:15 – 09:30
THE APPROACH IN THE EMERGINING AND BROAD SCENE IN INDIA
Banshi Saboo,
Dia Care to Diabetes Care & Hormone Clinic at Ahmedabad, India

(09:30 – 09:40) Short technical break

  09:40 – 10:40

Plenary hall (Manhattan 1-9)

TRANSFORMATIVE TEAM-BASED CARE

Chair: Shlomo Vinker, Tel Aviv University, Israel

09:40 – 09:55
ENHANCING QUALITY OF CARE AND OUTCOMES
Ana Cebrián Cuenca, Murcian Health Service, Spain

09:55 – 10:40
Panel Discussion: EMPOWERING FAMILY PHYSICIANS
Moderators: Michalina Bou-Matar, Polish Society of Family Medicine (PTMR), Poland
Thomas Frese, Institute of General Practice and Family Medicine, Germany

Panelists:
Justyna Ledwoch, Polish Society of Family Medicine (PTMR), Poland
Baruch Itzhak, Clalit Health Services, Israel
Ana Cebrián Cuenca, Murcian Health Service, Spain

  10:40 – 11:10

Exhibition & Networking Area (Manhattan 10-13)

COFFEE BREAK AND NETWORKING

  11:10 – 12:10

Plenary hall (Manhattan 1-9)

INDUSTRY SYMPOSIUM

Industry session not included in the main event CME/CPD credit. For more information, please click here.

  12:10 – 13:30

Exhibition & Networking Area (Manhattan 10-13)

LUNCH AND ORAL PRESENTATIONS

Chair:
Magdalena Bujnowska-Fedak, Wroclaw Medical University, Poland

12:30-12:38
MACHINE LEARNING IDENTIFIES PATTERNS IN MICROBIOME COMPOSITION IN TYPE 2 DIABETES PATIENTS
Dominika Tomczyk, Utrecht University, Netherlands

12:38-12:46
SIGNS OF MYOCARDIAL FIBROSIS IN PATIENTS WITH OBESITY WITHOUT CARDIOVASCULAR DISEASE
Ivanna Zubovych, The Scientific and Practical Medical Center of Pediatric Cardiology and Cardiac Surgery of the Ministry of Health, Ukraine

12:46-12:54
REAL-WORLD DATA FOR TIRZEPATIDE TREATMENT IN TYPE 2 DIABETES MELLITUS (T2DM) TO ADDRESS HBA1C AND OBESITY WITH CONSIDERATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Victoria L. Scott, Marsh Medical Practice, United Kingdom

12:54-13:02
REAL WORLD STUDY OF TIRZEPATIDE IN A SECONDARY CARE SPECIALIST DIABETES SERVICE IN THE UNITED KINGDOM (UK)
David T. Otuonye, Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, United Kingdom

13:02-13:10
TREATMENT WITH A NOVEL ZINC-SIDEROPHORE COMPLEX MINIMIZES (UP TO COMPLETE ELIMINATION) OF THE INSULIN RESISTANCE IN TYPE 2 DIABETIC ANIMAL MODELS
Mordechai M. Chevion, Hebrew University of Jerusalem, Israel

13:10-13:18
TRAINING PROGRAM FOCUSED AT IMPROVING MUSCULOSKELETAL PAIN AND WEIGHT LOSS IN PATIENTS WITH OBESITY
Carla Romagnolli, University of Sao Paulo, Brazil

13:18-13:26
STRATEGY FOR SCREENING AND MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PRIMARY CARE

Ana Guida Araujo Freitas, USF Beira Saúde, Portugal

 13:30 – 15:00

Plenary hall (Manhattan 1-9)

THE HEART IN THE MIDDLE OF CaReMeLO

Chairs:
Magdalena Kędziora, Polish Society of Family Medicine (PTMR), Poland
Paweł Balsam, Medical University of Warsaw, Poland

13:30 – 14:30
MASTERING THE BASICS INCLUDING ECHO WORKSHOP
Nir Flint, Tel Aviv Medical Center, Israel
Baruch Itzhak, Clalit Health Services, Israel

14:30 – 15:00
PILLARS OF THERAPY IN HEART FAILURE
Jan Biegus, Wroclaw Medical University, Poland

(15:00 – 15:10) Short technical break

  15:10 – 16:10

Plenary hall (Manhattan 1-9)

NAVIGATING LIVER CHALLENGES IN CaReMeLO: INTEGRATING MODERN THERAPIES

Chair: Joanna Szeląg, Polish Society of Family Medicine (PTMR), Poland

15:10 – 15:30
THE LIVER AS THE NEXUS IN CAREMELO PATIENTS
Luisa Vonghia, Antwerp University Hospital, Belgium

15:30 – 15:50
CASE STUDY: A CAREMELO PATIENT WITH MASH AND MULTISYSTEM INVOLVEMENT
Juan Mendive, Catalan Health Institute, Spain
Joanna Szeląg, Polish Society of Family Medicine (PTMR), Poland

15:50 – 16:10
THE CROSSTALK BETWEEN THE PCP AND SPECIALIST IN THE CARE OF MASLD
Luisa Vonghia, Antwerp University Hospital, Belgium
Juan Mendive, Catalan Health Institute, Spain

  16:10 – 16:40

Exhibition & Networking Area (Manhattan 10-13)

COFFEE BREAK AND NETWORKING

  16:40 – 18:30

Plenary hall (Manhattan 1-9)

INDUSTRY SYMPOSIUM

Industry session not included in the main event CME/CPD credit. For more information, please click here.

(18:30 – 18:40) Short technical break

  18:40 – 19:40

Plenary hall (Manhattan 1-9)

THE KIDNEY IN THE MIDDLE OF CaReMeLO

Chair: Per-Henrik Groop, University of Helsinki and Helsinki University Hospital, Finland

18:40 – 19:10
WHY THE KIDNEY IS CENTRAL TO CaReMeLO CARE AND HOW TO APPROACH ITS CARE
David Wheeler, University College London, United Kingdom

19:10 – 19:40
CASE STUDY: MULTIDISCIPLINARY MANAGEMENT OF CKD IN CaReMeLO PATIENTS
David Wheeler, University College London, United Kingdom
Joanna Iskra-Trifunović, AGMED Medical Center Poland

  19:40 – 20:00

Plenary hall (Manhattan 1-9)

THE CLOSING SESSION: PATH FORWARD AND KEY TAKEAWAYS

Avraham Karasik, Tel Aviv University, Israel

Baruch Itzhak, Clalit Health Services, Israel

Josep Vilaseca, University of Vic – University of Central Catalonia, Spain

Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland

Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland

*The program could be subject to changes.